P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.

Detalles Bibliográficos
Autores principales: Xavier-Ferrucio, J., Luo, C., Angelini, G., Krishnamurthy, S., Patel, N., Pettiglio, M., Collingsworth, T., Isik, M., Ghodssi, A., Halfond, A., Etchin, J., Keschner, Y., Mundelboim, G., Tavares, P., Cummins, C., Falla, A., Hazelbaker, D., Paik, E., Sanchez, J., Ge, G., Lydeard, J., Lin, M. I., Chakraborty, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431284/
http://dx.doi.org/10.1097/01.HS9.0000848572.60330.2f
_version_ 1784780012025544704
author Xavier-Ferrucio, J.
Luo, C.
Angelini, G.
Krishnamurthy, S.
Patel, N.
Pettiglio, M.
Collingsworth, T.
Isik, M.
Ghodssi, A.
Halfond, A.
Etchin, J.
Keschner, Y.
Mundelboim, G.
Tavares, P.
Cummins, C.
Falla, A.
Hazelbaker, D.
Paik, E.
Sanchez, J.
Ge, G.
Lydeard, J.
Lin, M. I.
Chakraborty, T.
author_facet Xavier-Ferrucio, J.
Luo, C.
Angelini, G.
Krishnamurthy, S.
Patel, N.
Pettiglio, M.
Collingsworth, T.
Isik, M.
Ghodssi, A.
Halfond, A.
Etchin, J.
Keschner, Y.
Mundelboim, G.
Tavares, P.
Cummins, C.
Falla, A.
Hazelbaker, D.
Paik, E.
Sanchez, J.
Ge, G.
Lydeard, J.
Lin, M. I.
Chakraborty, T.
author_sort Xavier-Ferrucio, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9431284
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94312842022-08-31 P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. Xavier-Ferrucio, J. Luo, C. Angelini, G. Krishnamurthy, S. Patel, N. Pettiglio, M. Collingsworth, T. Isik, M. Ghodssi, A. Halfond, A. Etchin, J. Keschner, Y. Mundelboim, G. Tavares, P. Cummins, C. Falla, A. Hazelbaker, D. Paik, E. Sanchez, J. Ge, G. Lydeard, J. Lin, M. I. Chakraborty, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431284/ http://dx.doi.org/10.1097/01.HS9.0000848572.60330.2f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Xavier-Ferrucio, J.
Luo, C.
Angelini, G.
Krishnamurthy, S.
Patel, N.
Pettiglio, M.
Collingsworth, T.
Isik, M.
Ghodssi, A.
Halfond, A.
Etchin, J.
Keschner, Y.
Mundelboim, G.
Tavares, P.
Cummins, C.
Falla, A.
Hazelbaker, D.
Paik, E.
Sanchez, J.
Ge, G.
Lydeard, J.
Lin, M. I.
Chakraborty, T.
P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
title P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
title_full P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
title_fullStr P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
title_full_unstemmed P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
title_short P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT.
title_sort p1429: multiplex deletion of myeloid antigens cd33 and cll-1 by crispr/cas9 in human hematopoietic stem cells highlights the potential of next-generation transplants for aml treatment.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431284/
http://dx.doi.org/10.1097/01.HS9.0000848572.60330.2f
work_keys_str_mv AT xavierferrucioj p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT luoc p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT angelinig p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT krishnamurthys p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT pateln p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT pettigliom p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT collingswortht p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT isikm p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT ghodssia p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT halfonda p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT etchinj p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT keschnery p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT mundelboimg p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT tavaresp p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT cumminsc p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT fallaa p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT hazelbakerd p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT paike p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT sanchezj p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT geg p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT lydeardj p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT linmi p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment
AT chakrabortyt p1429multiplexdeletionofmyeloidantigenscd33andcll1bycrisprcas9inhumanhematopoieticstemcellshighlightsthepotentialofnextgenerationtransplantsforamltreatment

Ejemplares similares